Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation in Cholera Patients
NCT00226616Phase 3Completed
- Sponsor
- icddr,b
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholera comparing Zinc Group with Placebo Group (2 arms). Primary endpoints: Reduction in duration of diarrhoea and Reduction in total stool volume. Started Nov 2000; status: completed.
02
Drugs
zinc acetate
03
Conditions
cholera
Beyond the preview
Go deeper on NCT00226616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226616.